Explore All Access
Check if your research matches the topics covered in JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY?
- Degree of match
- Common matching concepts
- Additional journal recommendations
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY : Impact Factor & More
eISSN: 2330-7757pISSN: 2330-7749
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY Journal Specifications
| Overview | |
| Publisher | FRONTLINE MEDICAL COMMUNICATIONS |
| Frequency | Monthly |
| General Details | |
| Frequency | Monthly |
| Website URL | Visit website |
View less
Planning to publish in JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY
Elevated liver function tests in a patient on palbociclib and fulvestrant
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Comparing risk models guiding growth factor use in chemotherapy
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
With this year’s close, the end of an era
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Symptom burdens related to chemotherapy-induced anemia in stage IV cancer
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Paradigm-changing osimertinib approval in front-line for advanced NSCLC
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Elevated liver function tests in a patient on palbociclib and fulvestrant
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Comparing risk models guiding growth factor use in chemotherapy
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
With this year’s close, the end of an era
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Symptom burdens related to chemotherapy-induced anemia in stage IV cancer
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
Paradigm-changing osimertinib approval in front-line for advanced NSCLC
- 1 Dec 2018
- The Journal of Community and Supportive Oncology
FAQs on JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY
What is the publishing frequency of JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY? 
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY published with a Monthly frequency.
How many articles did JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY publish last year?
In 2023, JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY publsihed undefined articles.
What is the eISSN & pISSN for JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY?
For JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, eISSN is 2330-7757 and pISSN is 2330-7749.
Who is the publisher of JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY?
FRONTLINE MEDICAL COMMUNICATIONS is the publisher of JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY.
